Sophia Kwon1, George Crowley1, Erin J Caraher1, Syed Hissam Haider1, Rachel Lam1, Arul Veerappan1, Lei Yang2, Mengling Liu2, Rachel Zeig-Owens3, Theresa M Schwartz3, David J Prezant3, Anna Nolan4. 1. Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, New York, NY. 2. Division of Biostatistics, Department of Population Health, New York University School of Medicine, New York, NY. 3. Bureau of Health Services and Office of Medical Affairs, Fire Department of New York, New York, NY; Pulmonary Medicine Division, Department of Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, New York, NY. 4. Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, New York, NY; Department of Environmental Medicine, New York University School of Medicine, New York, NY; Bureau of Health Services and Office of Medical Affairs, Fire Department of New York, New York, NY. Electronic address: anna.nolan@med.nyu.edu.
Abstract
BACKGROUND: Metabolic syndrome (MetSyn) predicted future development of World Trade Center lung injury (WTC-LI) in a subgroup of firefighters who never smoked and were male. An intracohort validation of MetSyn as a predictor of WTC-LI is examined in the cohort exposed to the World Trade Center (WTC) that has been followed longitudinally for 16 years. METHODS: Results of pulmonary function tests (n = 98,221) in workers exposed to the WTC (n = 9,566) were evaluated. A baseline cohort of firefighters who had normal FEV1 before 9/11 and who had had serum drawn before site closure on July 24, 2002 (n = 7,487) was investigated. Case subjects with WTC-LI (n = 1,208) were identified if they had at least two measured instances of FEV1 less than the lower limit of normal (LLN). Cox proportional hazards modeled early MetSyn biomarker ability to predict development of FEV1 less than the LLN. RESULTS: Case subjects were more likely to smoke, be highly exposed, and have MetSyn. There was a significant exposure dose response; the individuals most highly exposed had a 30.1% increased risk of developing WTC-LI, having MetSyn increased risk of developing WTC-LI by 55.7%, and smoking increased risk by 15.2%. There was significant interaction between smoking and exposure. CONCLUSIONS: We validated the usefulness of MetSyn to predict future WTC-LI in a larger population of individuals who were exposed. MetSyn defined by dyslipidemia, insulin resistance, and cardiovascular disease suggests that systemic inflammation can contribute to future lung function loss.
BACKGROUND:Metabolic syndrome (MetSyn) predicted future development of World Trade Center lung injury (WTC-LI) in a subgroup of firefighters who never smoked and were male. An intracohort validation of MetSyn as a predictor of WTC-LI is examined in the cohort exposed to the World Trade Center (WTC) that has been followed longitudinally for 16 years. METHODS: Results of pulmonary function tests (n = 98,221) in workers exposed to the WTC (n = 9,566) were evaluated. A baseline cohort of firefighters who had normal FEV1 before 9/11 and who had had serum drawn before site closure on July 24, 2002 (n = 7,487) was investigated. Case subjects with WTC-LI (n = 1,208) were identified if they had at least two measured instances of FEV1 less than the lower limit of normal (LLN). Cox proportional hazards modeled early MetSyn biomarker ability to predict development of FEV1 less than the LLN. RESULTS: Case subjects were more likely to smoke, be highly exposed, and have MetSyn. There was a significant exposure dose response; the individuals most highly exposed had a 30.1% increased risk of developing WTC-LI, having MetSyn increased risk of developing WTC-LI by 55.7%, and smoking increased risk by 15.2%. There was significant interaction between smoking and exposure. CONCLUSIONS: We validated the usefulness of MetSyn to predict future WTC-LI in a larger population of individuals who were exposed. MetSyn defined by dyslipidemia, insulin resistance, and cardiovascular disease suggests that systemic inflammation can contribute to future lung function loss.
Authors: Thomas K Aldrich; Madeline Vossbrinck; Rachel Zeig-Owens; Charles B Hall; Theresa M Schwartz; William Moir; Mayris P Webber; Hillel W Cohen; Anna Nolan; Michael D Weiden; Vasilios Christodoulou; Kerry J Kelly; David J Prezant Journal: Chest Date: 2016-01-13 Impact factor: 9.410
Authors: Scott M Grundy; James I Cleeman; Stephen R Daniels; Karen A Donato; Robert H Eckel; Barry A Franklin; David J Gordon; Ronald M Krauss; Peter J Savage; Sidney C Smith; John A Spertus; Fernando Costa Journal: Circulation Date: 2005-09-12 Impact factor: 29.690
Authors: Vanessa M McDonald; Peter G Gibson; Hayley A Scott; Penelope J Baines; Michael J Hensley; Jeffrey J Pretto; Lisa G Wood Journal: Respirology Date: 2016-02-24 Impact factor: 6.424
Authors: Edward J Schenck; Ghislaine C Echevarria; Francis G Girvin; Sophia Kwon; Ashley L Comfort; William N Rom; David J Prezant; Michael D Weiden; Anna Nolan Journal: BMJ Open Date: 2014-09-29 Impact factor: 2.692
Authors: Xiaoxue Liu; Jennifer Yip; Rachel Zeig-Owens; Jessica Weakley; Mayris P Webber; Theresa M Schwartz; David J Prezant; Michael D Weiden; Charles B Hall Journal: Front Public Health Date: 2017-02-08
Authors: Hee Jin Park; Ah Young Leem; Sang Hoon Lee; Ju Han Song; Moo Suk Park; Young Sam Kim; Se Kyu Kim; Joon Chang; Kyung Soo Chung Journal: Int J Chron Obstruct Pulmon Dis Date: 2015-08-07
Authors: Syed H Haider; Arul Veerappan; George Crowley; Erin J Caraher; Dean Ostrofsky; Mena Mikhail; Rachel Lam; Yuyan Wang; Maria Sunseri; Sophia Kwon; David J Prezant; Mengling Liu; Ann Marie Schmidt; Anna Nolan Journal: Am J Respir Cell Mol Biol Date: 2020-08 Impact factor: 6.914
Authors: Gabriele Grunig; Nedim Durmus; Yian Zhang; Yuting Lu; Sultan Pehlivan; Yuyan Wang; Kathleen Doo; Maria L Cotrina-Vidal; Roberta Goldring; Kenneth I Berger; Mengling Liu; Yongzhao Shao; Joan Reibman Journal: Int J Environ Res Public Health Date: 2022-07-01 Impact factor: 4.614
Authors: Sophia Kwon; Myeonggyun Lee; George Crowley; Theresa Schwartz; Rachel Zeig-Owens; David J Prezant; Mengling Liu; Anna Nolan Journal: Am J Respir Crit Care Med Date: 2021-11-01 Impact factor: 21.405
Authors: Sophia Kwon; George Crowley; Mena Mikhail; Rachel Lam; Emily Clementi; Rachel Zeig-Owens; Theresa M Schwartz; Mengling Liu; David J Prezant; Anna Nolan Journal: Int J Environ Res Public Health Date: 2019-04-26 Impact factor: 3.390
Authors: Julia Citron; Emma Willcocks; George Crowley; Sophia Kwon; Anna Nolan Journal: Int J Environ Res Public Health Date: 2019-11-07 Impact factor: 3.390
Authors: Sophia Kwon; Jessica Riggs; George Crowley; Rachel Lam; Isabel R Young; Christine Nayar; Maria Sunseri; Mena Mikhail; Dean Ostrofsky; Arul Veerappan; Rachel Zeig-Owens; Theresa Schwartz; Hilary Colbeth; Mengling Liu; Mary Lou Pompeii; David St-Jules; David J Prezant; Mary Ann Sevick; Anna Nolan Journal: Int J Environ Res Public Health Date: 2020-09-09 Impact factor: 3.390